Open access peer-reviewed chapter

Autophagy in Preeclampsia

Written By

Priscila Rezeck Nunes, Leandro Gustavo de Oliveira, Mariana Romão Veiga and Maria Terezinha Serrão Peraçoli

Submitted: November 13th, 2018 Reviewed: March 3rd, 2019 Published: May 6th, 2019

DOI: 10.5772/intechopen.85592

Chapter metrics overview

1,046 Chapter Downloads

View Full Metrics


Autophagy may be involved in gestation complicated by preeclampsia (PE) due to the presence of placental lesions caused by hypoxia at fetomaternal interphase. Autophagy is a lysosomal degradation pathway, removing protein aggregates and organelles damaged and thereby maintaining cell integrity. In preeclampsia, deficient myometrial penetration by extravillous cytotrophoblast occurs during the first trimester of pregnancy, leading to placental insufficiency. Several placental functions, like nutrient and oxygen input to the fetus during pregnancy, might benefit or even rely on autophagy and related material recycling within the cell. Deficiency in autophagy mechanism has been correlated to inflammatory responses. Autophagy is regulated during placentation and appears to be a possible factor in the development of preeclampsia. In this chapter, we intend to discuss evidence on autophagy pathway in pregnancy and the crosstalk between autophagy and inflammation in preeclampsia.


  • preeclampsia
  • autophagy
  • inflammasome
  • placenta
  • inflammation

1. Introduction

Autophagy is an intracellular degradation system conserved among eukaryotes [1] characterized as a natural defense mechanism capable to reduce damages related to inflammatory responses and infectious, neoplasia and degenerative diseases. Defects in this process are directly linked to several diseases [2, 3]. The main role of autophagy is to maintain cellular homeostasis by recycling intracellular materials. Cells under starvation or with organelle damage trigger the autophagy mechanism in order to clean their cytoplasm and restore a source of energy [4, 5, 6].There are three types of autophagy: microautopahgy, chaperone-mediated autophagy, and macroautophagy [7]. The most characteristic process of autophagy is the macroautophagy. This process is characterized by the creation of a double membrane compartment in the cytoplasm called phagophore. This structure develops into an autophagosome, a double lipid bilayer membrane-bound structure. The autophagosome merges with lysosomes leading to the autolysosome formation. Continuing the process of autophagy, the autolysosome is finally degenerated, releasing in the cytosol a number of monomers that can be reused by the cell as important sources of energy (Figure 1) [8, 9].

Figure 1.

Autolysosome formation. The process starts with a development of a double membrane named phagophore. This structure develops into an autophagosome, merging with lysosomes to form the autolysosome. During the process of autophagy, the autolysosome is degraded, releasing monomers into the cytosol, which can be reused by the cell as a source of energy. Source: own authorship.

The beginning of the autophagy process is dependent on the inhibition of the mammalian target of rapamycin (mTOR) and then autophagy proteins become crucial to the completion of the cascade generated [5, 10]. In this manner, cells under sufficient nutrition or without structural damages maintain a state of activation of mTOR, keeping blocked the mechanism of autophagy. After being triggered, mTOR provides a catalytic subunit by two distinct multiprotein complexes, mTORC1 (mechanistic target of rapamycin complex 1), and mTORC2 (mechanistic target of rapamycin complex 2). Some proteins are common for both complexes (GβL and Deptor), but others reflect specific functions for each of them, as raptor for mTORC1 and rictor for mTORC2 [11]. Regarding functions, mTORC1 coordinates the synthesis of lipids and proteins to promote cell growth, while mTORC2 acts in the cytoskeletal actin control [12]. Therefore, mTORC1 complex finally establishes the autophagy process via ULK1 (mammalian ortholog of yeast autophagy-related gene 1) kinase activity. The process of autophagosome formation involves about 38 Atgs (autophagy-related genes), and the initial process of autophagy in mammals is controlled by Atg1/ULK complex, which consists in ULK1/2 (UNC-51-like kinase 1), mAtg13, FIP200 (interaction protein of 200KD, homolog of the yeast Atg17), and Atg101. During nutrient rich conditions or in the presence of cell integrity, mTORC1 phosphorylates and inhibits ULK1/2 and mAtg13, deregulating the contact between ULK and AMPK (AMP-activated protein kinase), a kinase with activation effect on ULK1. But under altered conditions, mTORC1 is inhibited, and the activation of ULK1/2 leads to phosphorylation and activation of mAtg13 and FIP200 [13].

Atg plays crucial roles as ubiquitin-like protein conjugation system that mediates protein lipidation and participation in autophagy-specific protein kinase complexes [14, 15] for accomplishment of autophagy. Atg1 and Atg12-Atg5 complexes are essential for the autophagic machinery. Another important gene is Atg8 (a yeast autophagy-related gene ortholog of LC3), a membrane marker during the formation of autophagosome. Atg9 transmembrane protein and regulators of its trafficking (Atg2 and Atg18) participate in the expansion of phagophore after the formation of the Atg1 complex. There are two systems, Atg12 (Atg5, Atg7, Atg10, Atg12, and Atg16) and Atg8 (Atg3, Atg4, Atg7, and Atg8), which are responsible for expansion of the vesicle [1, 16].

The establishment of the autophagy is also dependent of two proteins: beclin-1 protein and LC3 (light chain protein 3) [17, 18]. Beclin-1 (homolog of yeast Apg6/Vps30) promotes the recruitment of membranes to form the autophagosome, nucleation of the autophagic vesicle, and recruitment of proteins from the cytosol [19]. Three isoforms of LC3 have been described: LC3A, LC3B, and LC3C. After synthesis and activation (LC3-I to LC3-II), LC3-II for incorporating cytosolic denatured proteins and damaged organelles into the autophagosome [20, 21]. The relative amounts of LC3-II reflect autophagic activity [22]. Considering the autophagy pathway, LC3-II has been proposed to be used to measure autophagy activity. Defective autophagy caused by mutations or genetic alterations can lead to various clinical syndromes [23], such as static encephalopathy of childhood with neurodegeneration in adulthood (SENDA), Vici syndrome, hereditary spastic paraparesis, Parkinson’s disease, lysosomal storage disorders, cancer, and Crohn’s disease.

As a lysosomal degradation pathway, removing protein aggregates and organelles damaged, maintaining cell integrity, autophagy may be impaired in pregnant women with preeclampsia (PE) due to the presence of placental lesions caused by hypoxia/ischemia [24]. In preeclampsia, there is deficient myometrial penetration by extravillous cytotrophoblast during the first trimester of pregnancy, leading to placental insufficiency [25]. On the other hand, it has been reported that proteins related to autophagy, LC3-II, and beclin-1 are present in trophoblastic villi during normal pregnancy, and high levels of LC3-II are present in the placenta of pregnant women with severe preeclampsia [26]. The induction of hypoxia on choriocarcinoma cell line JEG-3 with the purpose of exploring the mechanism of regulatory proteins involved in autophagy showed a slight increase in the expression of LC3-II, with a reduction in beclin-1. Treatment of these cells with TNF-α induced a significant increase in the expression of LC3-II without modifying the expression of beclin-1. The results suggest that the increased autophagic activity mediated by LC3-II may be involved in the pathophysiology of preeclampsia [26].

Studies with autophagy in the placenta are scarce, and most of the work done employs cell lines or cultures of trophoblast cells in vitro to evaluate autophagy induced by nutrient deprivation and oxygen [27].

The systemic inflammatory response exacerbated in preeclampsia seems to be related to the release of substances capable of inducing inflammation as membrane fragments of syncytiotrophoblast, fetal DNA, soluble microparticles derived from leukocytes, and inflammatory cytokines in plasma of pregnant women, causing activation of cells of innate immunity [28, 29, 30]. Other cellular components present in plasma, such as protein derivatives, polysaccharides, and lipids, as well as extracellular matrix products are named “damage-associated molecular patterns” (DAMPS) and are considered important modulators of the inflammatory response. DAMPs are represented by molecules like uric acid, reactive oxygen intermediates, heat shock proteins (Hsp) [31], proteins released from dead cells, as the high mobility group box 1—HMGB1 [32], and products released from the extracellular matrix, such as fibronectin and hyaluronan [33, 34]. Both protein hsp70 [35, 36] and hyaluronan [37, 38] are elevated in plasma of pregnant women with preeclampsia and may be associated with systemic inflammation and oxidative stress. However, the role of these factors in the pathophysiology of preeclampsia is not well understood. A major cause of preeclampsia is the accumulation of reactive oxygen species (ROS), resulting in impaired antioxidant protection and activation of autophagy. According to research in trophoblasts, expression of LC3 and beclin-1 and the formation of autophagosomes are higher than in normal placentas, suggesting that autophagy is regulated during placentation and appears to be a possible factor in the development of preeclampsia [39].


2. Autophagy and placenta

The placental development requires multiples roles of autophagy. Experimental studies suggest that autophagy plays important functions in survival of neonates during nutritional deficiency at the early stage of birth [40]. Moreover, it was seen that the growth and remodeling of cervical fascia progress by autophagy regulation. Meanwhile, it has not been reported that autophagy affects differentiation of trophoblasts in pregnant women by LC3-II and beclin-1, markers which are analyzed and compared between term placentas, and in their first trimester of gestation [39]. Autophagy is essential for placental development and for maintaining pregnancy, and the disruption of autophagy in extravillous trophoblast (EVT) contributes to hypoplastic placentation. Placentas of patients with preeclampsia present high levels of autophagy, with lower LC3 activation, and higher apoptosis than normal pregnancies. When induced by external factors such as hypoxia, autophagy directly affects trophoblast infiltration during normal placental development [41].

The study of autophagy markers in preeclampsia demonstrated that there are different patterns during normal pregnancy and preeclampsia, in part, because of the environmental factors, like hypoxia. Cells exposed to hypoxic conditions demonstrated higher levels of LC3, beclin-1, and the autophagosome formation when compared to normal placentas. Saito and Nakashima [24] reported that poor placentation is induced by decreased infiltration of trophoblasts due to abnormal processing for autophagy, which is activated by soluble endoglin (sENG). Inactivation of autophagy represses trophoblast infiltration and vascular remodeling due to excessive hypoxia, causing poor placentation, as observed in preeclampsia [26]. Hung and collaborators showed that autophagy decreased with advancing of gestational age in placentas of normotensive women, through analyses of changes in LC3-II and p62 according to gestational weeks [42].

The determination of p62 levels also has a few reports and in addition with the analysis of LC3-II [2, 14, 43] may be important to determine autophagic status in the villous tissue.

This important finding has been the basis of several investigations on oxidative stress, an alteration identified in placental related disorders, and whether this oxidative stress is able to induce autophagy activation on placental explants. We developed an in vitro study with the objective of evaluating the effect of oxidative stress induced by hydrogen peroxide (H2O2) on the occurrence of autophagy activation in placental explants of pregnant women at term (39–40 weeks), without clinical or obstetric disorders identified and undergone to elective cesarean section. In the methodology, we intended to reproduce experimentally the pathophysiology of obstetric complications related to placental dysfunction caused by uterine circulatory alterations. These alterations are responsible for the establishment of the hypoxia-reoxygenation phenomenon also called as ischemia-reperfusion injury and consequent production of (ROS).

The results showed the higher gene expression of LC3-II, beclin-1, and p62 detected in cultures exposed to different concentrations of H2O2 and demonstrated that the oxidative stress generated was able to induce autophagy in placental explants (Figure 2). Material and methods of this experiment are shown as supplementary material to this chapter.

Figure 2.

Activation of autophagy in cultures exposed to different concentrations of hydrogen peroxide. mRNA expression of LC3-II (A), beclin-1 (B), and p62 (C) in placental explants. Results expressed as mean ± SD. * (p < 0.05) vs. 0; # (p < 0.05) vs. 0, 10, 100 μM (ANOVA). Source: own authorship.

Gene expression of LC3-II (Figure 2A) was increased in tissues exposed to the concentration of 1000 μM of H2O2 compared to the non-exposed cultures, which means that autophagy was more activated in this concentration, in response to the oxidative effect. Gene expression of beclin-1 and p62 (Figure 2B and C) increased in front of increasing concentrations of H2O2 with the maximum value in 1000 μM of H2O2, showing statistical difference (p < 0.05) when compared to controls.

In the present study, the higher gene expression of LC3-II, beclin-1, and p62 detected in cultures exposed to H2O2 demonstrated that the oxidative stress generated was able to induce autophagy in placental explants.

The high expressions of mRNA for LC3-II and TNF-α (Figure 3A and B) demonstrated in our study corroborate with other reports, showing that placental hypoxic environment and the presence of TNF-α caused a positive regulation in the autophagy-related protein LC3-II in a trophoblastic cell line [26].

Figure 3.

Pro-inflammatory cytokine profile in cultures exposed to different concentrations of hydrogen peroxide. Gene and protein expression of pro-inflammatory cytokines TNF-α(A/B) and IL-1β (C/D) in placental explants. Results expressed as mean ± SD. * (p < 0.05) vs. 0 (ANOVA). Source: own authorship.

Gene expressions of TNF-α and IL-1β were higher in explants cultured with 1000 μM of H2O2 with significant difference (p < 0.05) to culture without H2O2 (Figure 3A and C). The protein expressions of these cytokines (Figure 3B and D) were higher in the supernatants from concentrations of 100 to 1000 μM of H2O2, with difference (p < 0.05) to non-exposed and cultures with 10 μM of H2O2. The protein expression of IL-1 β was higher in 1000 μM of H2O2 (p < 0.05) than in the culture of 100 μM of H2O2 (Figure 3D).

The similar patterns of p62, beclin-1, and LC3-II gene expressions suggest the production of mRNA for the p62 protein transcription, which will be degraded during autophagy activation. This protein plays a significant role on the regulation of oxidative stress, degenerative diseases, and carcinogenesis [44].


3. Autophagy and inflammasomes

Inflammasome is a molecular platform composed of nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) proteins. It is required for the activation of caspase-1 and subsequent maturation of the pro-inflammatory cytokines interleukin-1β and IL-18 [45]. NLRs respond to different endogenous or exogenous stimuli and activate caspase-1. During inflammation, these pro-inflammatory molecules are maturated in inflammasomes, which are in part regulated by the autophagy mechanism.

Actually, autophagy can control endogenous inflammasome activators, such as pro-IL-1β, which regulates the secretion of IL-1β and IL-18, thereby preventing an exaggerated inflammation [9, 45, 46].The activation of the inflammasome NLRP3 occurs via two signals: the first signal is provided by NF-kB activators and is a prerequisite for inflammasome activation via NLRP3 expression in macrophages [47]; the second signal activates NLRP3 inflammasome directly and involves host-derived adenosine triphosphate (ATP), uric acid crystals, bacterial toxins, or particulate matter (Figure 4) [48].

Figure 4.

Activation of NLRP3 inflammasome. This process requires two signals: the first is dependent of NF-kB activators and the second demands ATP, uric acid crystals, bacterial toxins or particulate matter to activate NLRP3 inflammasome. Source: own authorship.

Some studies have demonstrated a mutual relationship between autophagy and inflammasomes. Autophagy negatively regulates inflammasome activation. Autophagy induction is dependent on the presence of specific inflammasome sensors, inflammasomes are ultimately degraded by autophagosomes via the selective autophagic receptor p62, and autophagy plays a role in the biogenesis and secretion of the pro-inflammatory cytokine IL-1β [45, 9, 49].

The role of autophagy in inflammasome regulation may depend on the context of danger signal. In the absence of a danger signal, autophagy can act removing IL-1β and inflammasome components while maintaining cellular homeostasis. In the presence of a danger signal, autophagy may act initially as a secretory pattern to diffuse inflammation while preventing cell death and pyroptosis. Recent studies showed that macrophages may activate autophagy in response to inflammasome activation, as a way to delay the onset of pyroptosis. According to the authors, the inhibition of autophagy resulted in increased activation of pyroptosis and the impact of these types of cell death regulation by autophagy need to be more studied on inflammatory process [50]. When genes of autophagy regulator Atg 16L1 or Atg7 are deleted or a chemical inhibitor of autophagy is applied, LPS-dependent inflammasome activation occurs suggesting that autophagy controls inflammasome activation and can limit production of cytokines IL-1β and IL-18 [51]. Induced autophagy to inhibit the inflammasome and excessive inflammation or marking directly specific NLRs (NOD-like receptors) to reduce its activity may be a promising strategy to reverse inflammatory process [52].

In the present study, the oxidative stress induced by H2O2 on placental explants contributed to the inflammatory profile generated by activating the NLRP3 inflammasome, caspase-1 and inducing the release of IL-1β (Figure 3C and D).

In a previous study published by our research group, we observed that some markers of oxidative stress, such as superoxide dismutase (SOD) and catalase are altered at high concentrations of hydrogen peroxide confirming that H2O2 induces oxidative stress on placental explants and demonstrated that this stress involves inflammasome activation [53].

We demonstrated that gene expressions of NLRP3 and caspase-1 have similar patterns, with greater expression in cultures exposed to the concentration of 1000 μM of H2O2, which means that this concentration was able to activate the NLRP3 inflammasome (Figure 5). The activation of this complex may occur as a consequence of a common form of cellular stress initiated by different stimuli, such as the release of ROS [54, 55].

Figure 5.

Inflammasome activation in placental explants in cultures exposed to different concentrations of hydrogen peroxide. mRNA expression of NLRP3 (A) and caspase-1 (B) in explants of placental explants. Results expressed as mean ± SD. * (p < 0.05) vs. 0, 10 μM (ANOVA). Source: own authorship.

The relationship between occurrence of inflammasome and autophagy activation may be explained by the elevation in gene expression of p62 under conditions of oxidative stress. Inflammasome can be degraded by autophagosomes through this protein [56].


4. Conclusion

Taken together, the results of the present study confirm that H2O2 induces oxidative stress in placental explants, demonstrated by activation of NLRP3 inflammasome, which in turn induce the autophagy activation in order to control the inflammatory state. Activation of inflammasome and autophagy are essential elements of the innate immune system, and disorders in these processes have been implicated in various inflammatory and infectious diseases [57]. Oxidative stress may also contribute to placental tissue senescence and to the pathophysiology of some placental-related disorders of pregnancy, such as preeclampsia and fetal growth restriction [56]. Thus, initiatives to reduce stress on trophoblastic tissue should be considered for future researches.

Many studies have observed the effects of supplementation to prevent the effects of oxidative stress and autophagy in preeclampsia, such as the use of antioxidants, vitamins C and E, calcium, resveratrol and some natural products [58, 59, 60, 61].

The use of natural products and hormones such as Vitamin D may be a new model to reduce inflammation by regulating autophagy, since there is a direct correlation between vitamin D levels and cell survival in pathologies associated with gestation. Vitamin D and its components such as vitamin D receptor (VDR) are molecules that are highly related to the autophagic process [62]. In this sense, the use of products with antioxidant and anti-inflammatory effects still need to be evaluated in order to reduce oxidative stress, induce autophagy, and decrease the activation of inflammasome in placental tissue.



Results showed in this chapter were supported by the Fundação de Amparo a Pesquisa do Estado de São Paulo, FAPESP (Grant No 2014/25611-5).


Conflict of interest

The authors declare that they have no conflict of interest.


Supplementary material

1. Material and methods

1.1 Study population and ethics statement

This study consisted of 15 healthy pregnant women with normal evolution of the pregnancy, with no personal history of hypertensive disorders in pregnancy. These pregnant women were admitted to the Obstetrics Unit of Botucatu Medical School, Sao Paulo State University, Botucatu, SP, Brazil between November 2015 and May 2016. Gestational age was calculated from the last menstrual period and confirmed by ultrasound dating. Exclusion criteria included chronic hypertension, multiple gestation, prior preeclampsia, illicit drug use, and preexisting medical conditions such as diabetes, cancer, acute infectious disease, cardiovascular, autoimmune, renal and hepatic diseases. The study was approved by the Ethics Committee of the Botucatu Medical School, and written informed consent was obtained from all women involved in the study (CAAE Protocol number: 37160614500005411).

1.2 Collection of placental tissue

All placentas from normotensive pregnant women were delivered by cesarean section, without labor and were examined macroscopically and processed within 10 min of delivery. Fragments of approximately 5 × 5 cm were immediately removed from the central region of the placenta, constituting samples of the villous cytotrophoblast and the syncytiotrophoblast region in contact with the maternal side (basal plate). After collection, the trophoblastic tissue was washed in buffered saline (PBS) and separated from the decidual layer that is normally adhered to the basal plate. The terminal portions of the villi were evidenced in PBS (the villi were seen floating freely in the liquid) and dissected in small sections to constitute explants.

1.3 Culture of placental explants with hydrogen peroxide

The amount of villi used was 11 mg of placental tissue that was cultured in each well of 24-well plates (SPL Life Sciences, Korea) for 24 h for stabilization [63]. Cultures were performed in vitro in the absence of hydrogen peroxide or in the presence of 10, 100, and 1,000 μM of H2O2 for 4 h and 24 h in RPMI 1640 culture medium supplemented with 2 mM L-glutamine (Sigma-Aldrich, St Louis, MO, USA), 40 mg/ml antibiotic/antimycotic (Sigma-Aldrich), and 10% fetal bovine serum (Gibco BRL Life Technologies, The Netherlands) inactivated (complete RPMI medium).

After the culture periods, the explants were removed and submitted to RNA extraction for further analysis of the expression of genes related to inflammation (cytokines), autophagy, and inflammasome. Culture supernatants were obtained, centrifuged at 2,000 g for 10 min and stored at −80°C for determination of cytokines.

1.4 Cell viability assay

The cell viability assay was conducted through the activity of the enzyme lactate dehydrogenase (LDH) in supernatants of placental explant after 24, 48, 72, and 96 h of culture and was determined by commercial kit (Sigma-Aldrich) according to the manufacturer’s instructions.

1.5 Evaluation of the expression of transcripts related to inflammation

The placental explants were evaluated for the expression of the genes encoding IL-1β, TNF-α, LC3-II, beclin-1, and p62 proteins at the transcriptional level. In addition, the gene expression of the inflammasome was evaluated through the NLRP3 and caspase-1 genes.

Total RNA was extracted from the placentas using the Total RNA Purification Kit (Norgen Biotek Corp., Thorold, Canada) according to the manufacturer’s protocol, and the Reverse Transcription-coupled polymerase chain reaction (RT-qPCR) was performed as described previously [64]. Briefly, isolated RNA was DNAse I Amp Grade (Invitrogen) treated. Subsequently, the synthesis of complementary DNA (cDNA) was conducted using ImProm-IITM Reverse Transcription System, according to manufacturer’s protocol. The RT-qPCR was made using RT GoTaq-qPCR Master Mix (Promega, Madison, WI, USA), and the primer sequences used in this study are listed in Table 1. Each reaction was set in duplicate and the conditions for the RT-qPCR were as follows: initial denaturation at 96°C for 2 min and then 40 cycles at 95°C for 15 s and 60°C for 60 s, followed by a melting curve. Expression values of the analyzed transcripts were normalized to that of the enzyme-encoding glyceraldehyde-3-phosphate dehydrogenase gene (GAPDH).

Gene Sequence (5′-3′) Name GeneBank
Caspase-1 Forward primer: (1065)AGACATCCCACAATGGGCTC(1084)
Reverse primer: (1172)TGAAAATCGAACCTTGCGGAAA(1151)
CASP1 NM_033292.3
NLRP3 Forward primer: (2826)GAGGAAAAGGAAGGCCGACA(2845)
Reverse primer: (2917)TGGCTGTTCACCAATCCATGA(2897)
NLRP3 NM_004895.4
IL-1β Forward primer: (544)GAGCAACAAGTGGTGTTCTCC(564)
Reverse primer: (653)AACACGCAGGACAGGTACAG(634)
IL1B NM_000576.2
TNF-α Forward primer: (325)GCTGCACTTTGGAGTGATCG(344)
Reverse primer: (462)GGGTTTGCTACAACATGGGC(443)
TNF NM_000594.3
p62 Forward primer: (159)CGCTTCAGCTTCTGCTGC(176)
Reverse primer: (308)GTCCTCATCGCGGTAGTGC(290)
SQSTM1 NM_003900.4
Beclin-1 Forward primer: (101)GTAGACCGGACTTGGGTGAC(120)
Reverse primer: (198)CATGGTGCTGTTGTTGGACG(179)
BECN1 NM_003766.3
LC3-II Forward primer: (517)CCAGGAAACCTTCGGCTTCT(536)
Reverse primer: (632)CGGTAGAGGCAGCTCAGTTC(613)
MP1LC3A NM_032514.3
GAPDH Forward primer: (684)CGTGGAAGGACTCATGACCA(703)
Reverse primer: (801)GGCAGGGATGATGTTCTGGA(782)
GAPDH NM_002046.4

Table 1.

Primers for inflammasome and autophagy proteins, cytokines, and GAPDH. Source: Gen Bank (

The calculation of the differential expression of selected genes was carried out by the data processing method compared with a standard curve [65]. To analyze relative gene expression, we standardized the RNA expression levels in all samples to that of a single RNA sample, which was set to a value of 100.

1.6 Cytokine determination

Cytokine concentrations in culture supernatants of placental explants were determined by enzyme-linked immunosorbent assay (ELISA), using Quantikine ELISA kits (R&D Systems) for TNF-α and IL-1β according to the manufacturer’s instructions. Assay sensitivity limits were 1.6 pg./mL for TNF-α and 3.9 pg./mL for IL-1β.

1.7 Statistical Analysis

All of the data were analyzed using one-way ANOVA, followed by post-hoc Tukey test using the statistical program PRISM (Graph Prism for Windows, version 6.01, GraphPad, EUA) to compare the difference among the groups. A p value less than 0.05 was considered to be statistically significant.


Key points

  1. Autophagy is an intracellular degradation system characterized as a natural defense mechanism capable to reduce damages related to inflammatory responses.

  2. The main role of autophagy is to maintain cellular homeostasis by recycling intracellular materials.

  3. Activation of inflammasome and autophagy are essential elements of the innate immune system, and disorders in these processes have been implicated in various inflammatory and infectious diseases.

  4. Oxidative stress may also contribute to placental tissue senescence and to the pathophysiology of some placental-related disorders of pregnancy, such as preeclampsia and fetal growth restriction.

  5. The use of products with antioxidant and anti-inflammatory effects still need to be evaluated in order to reduce oxidative stress, induce autophagy, and decrease the activation of inflammasome in placental tissue.


  1. 1. Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annual Review of Cell and Developmental Biology. 2011;27:107-132. DOI: 10.1146/annurev-cellbio-092910-154005
  2. 2. Jiang P, Mizushima N. LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells. Methods. 2014;75:18-22. DOI: 10.1016/j.ymeth.2014.11.021
  3. 3. Mizushima N, Komatsu M. Autophagy: Renovation of cells and tissues. Cell. 2011;147:728-741. DOI: 10.1016/j.cell.2011.10.026
  4. 4. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008;451:1069-1075. DOI: 10.1038/nature06639
  5. 5. Jo EK, Shin DM, Choi AMK. Autophagy: Cellular defense to excessive inflammation. Microbes and Infection. 2012;14:119-125. DOI: 10.1016/j.micinf.2011.08.014
  6. 6. Mizushima N, Klionsky DJ. Protein turnover via autophagy: implications for metabolism. Annual Review of Nutrition. 2007;27:19-40. DOI: 10.1146/annurev.nutr.27.061406.093749
  7. 7. Taylor P, Yue Y, Li J, Zhang S, Lin X, Chu J, et al. YY1-MIR372-SQSTM1 regulatory axis in autophagy. Autophagy. 2014;10:37-41. DOI: 10.4161/auto.29486.
  8. 8. Mulakkal NC, Nagy P, Takats S, Tusco R, Juhász G, Nezis IP. Autophagy in drosophila: From historical studies to current knowledge. BioMed Research International. 2014;2014:273473
  9. 9. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469:323-335. DOI: 10.1038/nature09782
  10. 10. Dragowska WH, Weppler SA, Qadir MA, Wong LY, Franssen Y, Baker JHE, et al. The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity. BMC Cancer. 2011;11:420. DOI: 10.1186/1471-2407-11-420
  11. 11. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J, et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKC a, but not S6K1. Developmental Cell. 2006;11(6):859-871. DOI: 10.1016/j.devcel.2006.10.007
  12. 12. Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA, Hall A, et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nature Cell Biology. 2004;6(11):1122-1128. DOI: 10.1038/ncb1183
  13. 13. Jung CH, Seo M, Otto NM, Kim D, Hwa C, Seo M, et al. ULK1 inhibits the kinase activity of mTORC1 and cell proliferation. Autophagy. 2011;7(10):1212-1221. DOI: 10.4161/auto.7.10.16660
  14. 14. Ichimura Y, Komatsu M. Selective degradation of p62 by autophagy. Seminars in Immunopathology. 2010;32:431-436. DOI: 10.1007/s00281-010-0220-1
  15. 15. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. The Journal of Cell Biology. 2000;150(6):1507-1513. DOI: 10.1083/jcb.150.6.1507
  16. 16. Klionsky DJ, Schulman BA. Dynamic regulation of macroautophagy by distinctive ubiquitin-like proteins. Nature Structural & Molecular Biology. 2014;21:336-345. DOI: 10.1038/nsmb.2787
  17. 17. Levine B, Yuan J. Autophagy in cell death: An innocent convict? The Journal of Clinical Investigation. 2005;115:2679-2688. DOI: 10.1172/JCI26390
  18. 18. Shintani T, Klionsky DJ. Autophagy in health and disease: A double-edged sword. Science. 2004;306:990-995. DOI: 10.1126/science.1099993
  19. 19. Ferraro E, Cecconi F. Autophagic and apoptotic response to stress signals in mammalian cells. Archives of Biochemistry and Biophysics. 2007;462:210-219. DOI: 10.1016/
  20. 20. Lamark T, Kirkin V, Dikic I, Johansen T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle. 2009;8:1986-1990. DOI: 10.4161/cc.8.13.8892
  21. 21. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:15077-15082. DOI: 10.1073/pnas.2436255100
  22. 22. Yorimitsu T, Klionsky DJ. Eating the endoplasmic reticulum: Quality control by autophagy. Trends in Cell Biology. 2007;17:279-285. DOI: 10.1016/j.tcb.2007.04.005
  23. 23. Jiang P, Mizushima N. Autophagy and human diseases. Cell Research. 2014;24(1):69-79. DOI: 10.1038/cr.2013.161
  24. 24. Saito S, Nakashima A. Review: The role of autophagy in extravillous trophoblast function under hypoxia. Placenta. 2013;34:S79-S84. DOI: 10.1016/j.placenta.2012.11.026
  25. 25. Huppertz B. Placental origins of preeclampsia: Challenging the current hypothesis. Hypertension. 2008;51(4):970-975. DOI: 10.1161/HYPERTENSIONAHA.107.107607
  26. 26. Oh S-Y, Choi S-J, Kim KH, Cho EY, Kim J-H, Roh C-R. Autophagy-related proteins, LC3 and Beclin-1, in placentas from pregnancies complicated by preeclampsia. Reproductive Sciences. 2008;15:912-920. DOI: 10.1177/1933719108319159
  27. 27. Curtis S, Jones CJP, Garrod A, Hulme CH, Heazell AEP. Identification of autophagic vacuoles and regulators of autophagy in villous trophoblast from normal term pregnancies and in fetal growth restriction. Journal of Maternal-Fetal and Neonatal Medicine. 2012;26:1-8. DOI: 10.3109/14767058.2012.733764
  28. 28. Redman CWG, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response—A review. Placenta. 2003;24:21-27. DOI: 10.1053/plac.2002.0930
  29. 29. Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Seminars in Fetal & Neonatal Medicine. 2006;11:309-316. DOI: 10.1016/j.siny.2006.04.001
  30. 30. Lok CA, Jebbink J, Nieuwland R, Faas MM, Boer K, Sturk A, et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. American Journal of Reproductive Immunology. 2009;61:346-359. DOI: 10.1111/j.1600-0897.2009.00701.x
  31. 31. Asea A, Rehli M, Kabingu E, Boch JA, Baré O, Auron PE, et al. Novel signal transduction pathway utilized by extracellular HSP70. Role of toll-like receptor (TLR) 2 and TLR4, The Journal of Biological Chemistry 277 (2002) 15028-15034. doi:10.1074/jbc.M200497200
  32. 32. Park JS, Svetkauskaite D, He Q , Kim J-Y, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. The Journal of Biological Chemistry. 2004;279:7370-7377. DOI: 10.1074/jbc.M306793200
  33. 33. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, et al. The extra domain a of fibronectin activates toll-like receptor 4. The Journal of Biological Chemistry. 2001;276:10229-10233. DOI: 10.1074/jbc.M100099200
  34. 34. Campo GM, Avenoso A, Campo S, D’Ascola A, Nastasi G, Calatroni A. Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes. Biochemical Pharmacology. 2010;80:480-490. DOI: 10.1016/j.bcp.2010.04.024
  35. 35. Molvarec A, Rigó J, Lázár L, Balogh K, Makó V, Cervenak L, et al. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress & Chaperones. 2009;14:151-159. DOI: 10.1007/s12192-008-0067-8
  36. 36. Peraçoli JC, Bannwart-Castro CF, Romao M, Weel IC, Ribeiro VR, Borges VTM, et al. High levels of heat shock protein 70 are associated with pro-inflammatory cytokines and may differentiate early- from late-onset preeclampsia. Journal of Reproductive Immunology. 2013;100:129-134. DOI: 10.1016/j.jri.2013.08.003
  37. 37. Romão M, Weel IC, Lifshitz SJ, Peraçoli MTS, Witkin SS. Elevated hyaluronan and extracellular matrix metalloproteinase inducer levels in women with preeclampsia. Archives of Gynecology and Obstetrics. 2014;289:575-579. DOI: 10.1007/s00404-013-3021-7
  38. 38. Romão-Veiga M, Matias ML, Ribeiro VR, Nunes PR, Borges VTM, Peraçoli JC, et al. Induction of systemic inflammation by hyaluronan and hsp70 in women with pre-eclampsia. Cytokine. 2018;105:23-31. DOI: 10.1016/j.cyto.2018.02.007
  39. 39. Gong J, Kim GJ. The role of autophagy in the placenta as a regulator of cell death. Clinical and Experimental Reproductive Medicine. 2014;41:97-107. DOI: 10.5653/cerm.2014.41.3.97
  40. 40. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, et al. The role of autophagy during the early neonatal starvation period. Nature. 2004;432:1032-1036. DOI: 10.1038/nature03029
  41. 41. Gong GU, Hu L, Liu Y, Bai S, Dai X. Upregulation of HIF-1 α protein induces mitochondrial autophagy in primary cortical cell cultures through the inhibition of the mTOR pathway. International Journal of Molecular Medicine. 2014;34:1133-1140. DOI: 10.3892/ijmm.2014.1850
  42. 42. Hung TH, Hsieh TTA, Chen SF, Li MJ, Yeh YL. Autophagy in the human placenta throughout gestation. PLoS One. 2013;8:1-11. DOI: 10.1371/journal.pone.0083475
  43. 43. Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell. 2009;137:1001-1004. DOI: 10.1016/j.cell.2009.05.023
  44. 44. Yuk J, Jo E. Crosstalk between autophagy and Inflammasomes. Molecules and Cells. 2013;36:393-399. DOI: 10.1007/s10059-013-0298-0
  45. 45. Deretic V. Autophagy: An emerging immunological paradigm. Journal of Immunology. 2012;189:15-20. DOI: 10.4049/jimmunol.1102108
  46. 46. Arroyo DS, Gaviglio EA, Ramos JMP, Bussi C, Rodriguez-galan MC, Iribarren P. Autophagy in inflammation, infection, neurodegeneration and cancer. International Immunopharmacology. 2014;18:55-65. DOI: 10.1016/j.intimp.2013.11.001
  47. 47. Bauernfeind F, Horvath G, Stutz A, Alnemri ES, Speert D, Fernandes-alnemri T, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. Journal of Immunology. 2009;183(2):787-791. DOI: 10.4049/jimmunol.0901363
  48. 48. Chen GY, Nuñez G. Sterile inflammation: Sensing and reacting to damage. Nature Reviews. Immunology. 2010;10(12):826-837. DOI: 10.1038/nri2873
  49. 49. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1 b. The EMBO Journal. 2011;30:4701-4711. DOI: 10.1038/emboj.2011.398
  50. 50. Byrne BG, Dubuisson JF, Joshi AD, Persson JJ, Swanson MS. Inflammasome components coordinate autophagy and pyroptosis as macrophage responses to infection. MBio. 2013;4(1):e00620-e00612. DOI: 10.1128/mBio.00620-12
  51. 51. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang B-G, Satoh T, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008;456:264-268. DOI: 10.1038/nature07383
  52. 52. Martins JD, Liberal J, Silva A, Ferreira I, Neves BM, Cruz MT. Autophagy and inflammasome interplay. DNA and Cell Biology. 2015;34:150310073853004. DOI: 10.1089/dna.2014.2752
  53. 53. Nunes PR, Peracoli MTS, Romao-Veiga M, Matias ML, Ribeiro VR, Da Costa Fernandes CJ, et al. Hydrogen peroxide-mediated oxidative stress induces inflammasome activation in term human placental explants. Pregnancy Hypertension. 2018;14:29-36. DOI: 10.1016/j.preghy.2018.07.006
  54. 54. Martinon F. Signaling by ROS drives inflammasome activation. European Journal of Immunology. 2010;40(3):616-619. DOI: 10.1002/eji.200940168
  55. 55. Lamkanfi M, Vande L, Walle L, Kanneganti TD. Deregulated inflammasome signaling in disease. Immunological Reviews. 2011;243(1):163-173. DOI: 10.1111/j.1600-065X.2011.01042.x
  56. 56. Lin X, Li S, Zhao Y, Zhang K, He X, Wang Z. Interaction domains of p62: A bridge between p62 and selective autophagy. DNA and Cell Biology. 2013;32(5):220-227. DOI: 10.1089/dna.2012.1915
  57. 57. Harris J. Autophagy and cytokines. Cytokine. 2011;56:140-144. DOI: 10.1016/j.cyto.2011.08.022
  58. 58. Hutabarat M, Wibowo N, Obermayer-Pietsch B, Huppertz B. Impact of vitamin D and vitamin D receptor on the trophoblast survival capacity in preeclampsia. PLoS One. 2018;8(13):11, e0206725. DOI: 10.1371/journal.pone.0206725. eCollection 2018
  59. 59. Bujold E, Hyett J. Calcium supplementation for prevention of pre-eclampsia. Lancet. 2019;393(10169):298-300. DOI: 10.1016/S0140-6736(18)32161-5
  60. 60. Romero R, Garite TJ. Unexpected results of an important trial of vitamins C and E administration to prevent preeclampsia. American Journal of Obstetrics and Gynecology. 2006;194(5):1213-1214
  61. 61. Roberts JM, Speer P. Antioxidant therapy to prevent preeclampsia. Seminars in Nephrology. 2004;24(6):557-564
  62. 62. Zou Y, Zuo Q , Huang S, Yu Z, Jiang Z, Zou S, et al. Resveratrol inhibits trophoblast apoptosis through oxidative stress in preeclampsia-model rats. Molecules. 2014;19(12):20570-20579. DOI: 10.3390/molecules191220570
  63. 63. Yu J, Feng L, Hu Y, Zhou Y. Effects of SAC on oxidative stress and NO availability in placenta: potential benefits to preeclampsia. Placenta. 2012;33:487-494
  64. 64. Matias ML et al. Endogenous and uric acid-induced activation of NLRP3 inflammasome in pregnant women with preeclampsia. PLoS One. 2015;10:e0129095
  65. 65. Larionov A, Krause A, Miller W. A standard curve based method for relative real time PCR data processing. BMC Bioinformatics. 2005;6:62. DOI: 10.1186/1471-2105-6-62

Written By

Priscila Rezeck Nunes, Leandro Gustavo de Oliveira, Mariana Romão Veiga and Maria Terezinha Serrão Peraçoli

Submitted: November 13th, 2018 Reviewed: March 3rd, 2019 Published: May 6th, 2019